Tower Research Capital LLC (Trc) Immuno Gen, Inc. Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$12.46 - $29.95 $555,915 - $1.34 Million	44,616 Added 849.18%	49,870 $1.48 Million
Q3 2023 Nov 14, 2023	SELL	$14.09 - $19.87 $81,271 - $114,610	-5,768 Reduced 52.33%	5,254 $83,000
Q2 2023 Aug 14, 2023	SELL	$3.75 - $20.05 $4,447 - $23,779	-1,186 Reduced 9.71%	11,022 $207,000
Q1 2023 May 09, 2023	SELL	$3.67 - $4.92 $131,565 - $176,377	-35,849 Reduced 74.6%	12,208 $47,000
Q4 2022 Feb 10, 2023	SELL	$4.55 - $6.31 $252,060 - $349,561	-55,398 Reduced 53.55%	48,057 $238,000
Q3 2022 Nov 10, 2022	BUY	$4.48 - $6.47 $241,274 - $348,448	53,856 Added 108.58%	103,455 $495,000
Q2 2022 Aug 15, 2022	BUY	$3.15 - $5.76 $141,529 - $258,796	44,930 Added 962.3%	49,599 $223,000
Q1 2022 May 12, 2022	SELL	$4.26 - $7.48 $84,071 - $147,617	-19,735 Reduced 80.87%	4,669 $23,000
Q4 2021 Feb 14, 2022	SELL	$4.75 - $7.5 $79,933 - $126,210	-16,828 Reduced 40.81%	24,404 $181,000
Q3 2021 Nov 15, 2021	BUY	$5.02 - $6.59 $144,887 - $190,200	28,862 Added 233.32%	41,232 $234,000
Q2 2021 Aug 16, 2021	SELL	$5.79 - $8.6 $56,215 - $83,497	-9,709 Reduced 43.97%	12,370 $82,000
Q1 2021 May 17, 2021	BUY	$6.5 - $10.53 $107,302 - $173,829	16,508 Added 296.32%	22,079 $179,000
Q4 2020 Feb 16, 2021	SELL	$3.7 - $7.66 $918,277 - $1.9 Million	-248,183 Reduced 97.8%	5,571 $36,000
Q3 2020 Nov 16, 2020	BUY	$3.45 - $4.89 $685,863 - $972,136	198,801 Added 361.77%	253,754 $913,000
Q2 2020 Aug 13, 2020	BUY	$3.32 - $5.34 $182,443 - $293,449	54,953 New	54,953 $253,000
Q1 2020 May 15, 2020	SELL	$2.12 - $6.8 $536 - $1,720	-253 Closed	0 $0
Q4 2019 Feb 07, 2020	SELL	$2.25 - $5.8 $74,531 - $192,125	-33,125 Reduced 99.24%	253 $1,000
Q3 2019 Nov 05, 2019	BUY	$2.22 - $3.39 $74,099 - $113,151	33,378 New	33,378 $81,000
Q2 2019 Aug 13, 2019	SELL	$1.8 - $3.3 $691 - $1,267	-384 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$2.41 - $5.91 $2,954 - $7,245	-1,226 Reduced 76.15%	384 $1,000
Q4 2018 Feb 14, 2019	SELL	$3.94 - $9.7 $15,858 - $39,042	-4,025 Reduced 71.43%	1,610 $8,000
Q3 2018 Nov 13, 2018	BUY	$8.6 - $11.26 $48,461 - $63,450	5,635 New	5,635 $53,000
Q2 2018 Aug 15, 2018	SELL	$9.52 - $12.15 $64,536 - $82,364	-6,779 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$6.7 - $12.95 $43,416 - $83,916	6,480 Added 2167.22%	6,779 $71,000
Q4 2017 Feb 09, 2018	SELL	$5.07 - $7.92 $1,363 - $2,130	-269 Reduced 47.36%	299 $2,000
Q3 2017 Nov 14, 2017	BUY	$5.4 - $8.47 $3,067 - $4,810	568	568 $4,000

Others Institutions Holding IMGN

# of Institutions

Shares Held

1.41M

Call Options Held

Put Options Held

View Full List

About ImmunoGen, Inc.

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

More about IMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account